Ozempic, weight-loss ‘wonder drug’, under scrutiny amid suicide risk claims
Al JazeeraOzempic has not shown increased risk of suicidal ideation in trials, but some users say it harmed their mental health. I had never once felt like I wanted to die.” After going off the medication with the help of a mental health professional, Niscior’s mental health went back to normal. Both the FDA and Danish manufacturer Novo Nordisk have pointed out that neither Ozempic nor its sister weight-loss drug Wegovy have shown any increased risk of suicidal ideation or behaviour in clinical trials. “The safety data collected from large clinical trial programmes and post-marketing surveillance have not demonstrated a causal association between semaglutide or liraglutide and suicidal and self-harming thoughts,” a Novo Nordisk spokesperson told Al Jazeera. “Novo Nordisk is continuously performing surveillance of the data from ongoing clinical trials and real-world use of its products and collaborates closely with the authorities to ensure patient safety and adequate information to healthcare professionals.” Ozempic and Wegovy, which contain the same active ingredient, semaglutide, have exploded in popularity over the past year.